Skip to main content

Research team Katja Pokrovskaja Tamm

Novel targeted therapies in cancer to overcome drug resistance

Projects

Autophagy in anti-cancer therapy
Molecular mechanisms underlying pediatric leukemia development and treatment
STAT3 as a target in anti-cancer therapy

Funding

  • Swedish Cancer Society (Mechanisms of action of anti-cancer drugs and therapy resistance, STAT3 in cancer and therapy resistance)
  • The Swedish Childhood Cancer Foundation (Molecular mechanisms underlying pediatric leukemia development and treatment)
  • Swedish foundation for Strategic Research (Autophagy in anti-cancer therapy)
  • The Cancer Society in Stockholm (Drug development to overcome drug resistance and the Role of non-coding RNA in cancer, STAT3 activation in cancer and therapy resistance)
  • Karolinska Institutet, KID (STAT3 as a target for anti-cancer therapy)

Group members

Katja Pokrovskaja Tamm, PI, PhD, Associate Professor
Elin Edsbäcker, postdoc
Yasmin Yu, MSc, PhD student

Affiliated

Angelo de Milito, Associate Professor, Sprint Bioscience, Huddinge
Santiago Parpal, Researcher, Sprint Bioscience, Huddinge

Selected publications

30679726

30055290

30154400

28636670

25156627

23246572

22829187

19390558